Teladoc Health, Inc. (0LDR.L)
USD 9.55
(-4.89%)
USD 9.55
(-4.89%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.59 Billion USD | 1.2% |
| 2022 | 1.57 Billion USD | 24.13% |
| 2021 | 1.26 Billion USD | -13.5% |
| 2020 | 1.46 Billion USD | 214.84% |
| 2019 | 465.4 Million USD | 12.23% |
| 2018 | 414.68 Million USD | 99.97% |
| 2017 | 207.37 Million USD | 366.8% |
| 2016 | 44.42 Million USD | 67.78% |
| 2015 | 26.47 Million USD | 1.72% |
| 2014 | 26.02 Million USD | 767.63% |
| 2013 | 3 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 1.57 Billion USD | 0.0% |
| 2024 Q1 | 1.59 Billion USD | -0.13% |
| 2024 Q2 | 1.58 Billion USD | -0.09% |
| 2023 Q3 | 1.57 Billion USD | -0.1% |
| 2023 Q4 | 1.59 Billion USD | 1.28% |
| 2023 FY | 1.59 Billion USD | 1.2% |
| 2023 Q1 | 1.57 Billion USD | -0.08% |
| 2023 Q2 | 1.57 Billion USD | 0.11% |
| 2022 Q2 | 1.57 Billion USD | 0.31% |
| 2022 Q1 | 1.57 Billion USD | 24.1% |
| 2022 Q4 | 1.57 Billion USD | -0.14% |
| 2022 FY | 1.57 Billion USD | 24.13% |
| 2022 Q3 | 1.57 Billion USD | -0.15% |
| 2021 Q4 | 1.26 Billion USD | 1.06% |
| 2021 Q2 | 1.23 Billion USD | -11.17% |
| 2021 Q3 | 1.25 Billion USD | 1.34% |
| 2021 FY | 1.26 Billion USD | -13.5% |
| 2021 Q1 | 1.39 Billion USD | -4.93% |
| 2020 Q4 | 1.46 Billion USD | 48.94% |
| 2020 FY | 1.46 Billion USD | 214.84% |
| 2020 Q3 | 983.81 Million USD | 0.2% |
| 2020 Q2 | 981.88 Million USD | 103.5% |
| 2020 Q1 | 482.48 Million USD | 3.67% |
| 2019 Q3 | 464.78 Million USD | 1.27% |
| 2019 Q1 | 449.22 Million USD | 8.33% |
| 2019 Q2 | 458.94 Million USD | 2.16% |
| 2019 FY | 465.4 Million USD | 12.23% |
| 2019 Q4 | 465.4 Million USD | 0.13% |
| 2018 Q2 | 402.75 Million USD | 91.39% |
| 2018 Q3 | 408.65 Million USD | 1.46% |
| 2018 FY | 414.68 Million USD | 99.97% |
| 2018 Q4 | 414.68 Million USD | 1.48% |
| 2018 Q1 | 210.43 Million USD | 1.48% |
| 2017 Q2 | 243.83 Million USD | 474.62% |
| 2017 Q1 | 42.43 Million USD | -4.48% |
| 2017 FY | 207.37 Million USD | 366.8% |
| 2017 Q4 | 207.37 Million USD | -44.15% |
| 2017 Q3 | 371.33 Million USD | 52.29% |
| 2016 Q1 | 26.2 Million USD | -1.02% |
| 2016 Q2 | 31.38 Million USD | 19.77% |
| 2016 FY | 44.42 Million USD | 67.78% |
| 2016 Q4 | 44.42 Million USD | -0.1% |
| 2016 Q3 | 44.46 Million USD | 41.68% |
| 2015 Q4 | 26.47 Million USD | -2.35% |
| 2015 Q3 | 27.11 Million USD | -16.98% |
| 2015 Q2 | 32.65 Million USD | 25.38% |
| 2015 Q1 | 26.04 Million USD | 0.07% |
| 2015 FY | 26.47 Million USD | 1.72% |
| 2014 Q4 | 26.02 Million USD | 0.0% |
| 2014 FY | 26.02 Million USD | 767.63% |
| 2014 Q1 | - USD | 0.0% |
| 2013 FY | 3 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -13187.799% |
| Accuray Incorporated | 172.15 Million USD | -824.904% |
| Align Technology, Inc. | 96.96 Million USD | -1542.064% |
| Elevance Health Inc. | 25.12 Billion USD | 93.661% |
| AxoGen, Inc. | 69.29 Million USD | -2197.923% |
| Boston Scientific Corporation | 9.09 Billion USD | 82.497% |
| CVS Health Corporation | 79.38 Billion USD | 97.994% |
| Cardinal Health, Inc. | 5.6 Billion USD | 71.612% |
| Centene Corporation | 17.69 Billion USD | 91.004% |
| DaVita Inc. | 11.11 Billion USD | 85.676% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 96.196% |
| Hologic, Inc. | 2.53 Billion USD | 37.178% |
| Humana Inc. | 10.21 Billion USD | 84.409% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -67.983% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 73.258% |
| Masimo Corporation | 970 Million USD | -64.152% |
| McKesson Corporation | 5.47 Billion USD | 70.901% |
| Patterson Companies, Inc. | 762.94 Million USD | -108.703% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 70.343% |
| ResMed Inc. | 873.93 Million USD | -82.196% |
| Henry Schein, Inc. | 2.74 Billion USD | 41.909% |
| Universal Health Services, Inc. | 5.36 Billion USD | 70.33% |
| Veeva Systems Inc. | 55.77 Million USD | -2754.822% |
| Baxter International Inc. | 14.36 Billion USD | 88.915% |
| Becton, Dickinson and Company | 15.87 Billion USD | 89.972% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -1673.137% |
| Danaher Corporation | 19.35 Billion USD | 91.774% |
| Stryker Corporation | 12.99 Billion USD | 87.747% |
| Medtronic plc | 24.96 Billion USD | 93.621% |